Mentice AB

MNTC · Nasdaq Stockholm · Healthcare

14.80SEK 0.0%last day

Price as of 2 October 2026

The price over the past year, with dividends: +26.0%

Performance

1 month

+9.2%

1 year

+26.0%

3 years, per year

−24.6%

5 years, per year

−37.6%

Largest fall, 3 years

−86.3%

Below the peak now

−92.0%

Volatility, 1 year

48.8%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

3.3

Dividend yield

0.0%

Return on equity

−3.7%

Net margin

−1.5%

Market value

41 m USD

Quality, value and trend

Where Mentice stands against every Nordic stock today. 100 is best.

Quality10

Profitability and a sound balance sheet over time. Better than 10% of Nordic stocks.

Value34

The price measured against earnings, assets and cash flow. Better than 34% of Nordic stocks.

Trend78

The price development over the past year. Better than 78% of Nordic stocks.

Combined29

Quality, value and trend together. Better than 29% of Nordic stocks.

About Mentice

Mentice AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 110 employees.

Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedural learning models; peripheral vascular; patient simulator accessories and extensions for endovascular therapies; and Angiosuite integrations, such as the VIST virtual patient and Laerdal SimMan vascular medical simulator.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis